MétaCan
Menu
Back to cohort
Record W4394961830 · doi:10.1002/ejhf.3236

A Roadmap for Therapeutic Discovery in Pulmonary Hypertension Associated with Left Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function

2024· article· en· W4394961830 on OpenAlexaff
Pietro Ameri, Valentina Mercurio, Piero Pollesello, Markus S. Anker, Johannes Backs, Antoni Bayés‐Genís, Barry A. Borlaug, Daniel Burkhoff, Sergio Caravita, Stephen Y. Chan, Frances S. de Man, George Giannakoulas, Aránzazu González, Marco Guazzi, Paul M. Hassoun, Anna R. Hemnes, Cristoph Maack, Brendan Madden, Vojtěch Melenovský, Oliver J. Müller, Zoltán Papp, Soni Savai Pullamsetti, Peter P. Rainer, Margaret M. Redfield, Stuart Rich, Gabriele G. Schiattarella, Hall Skaara, Konstantinos Stellos, Ryan J. Tedford, Thomas Thum, Jean Luc Vachiéry, Peter van der Meer, Sophie Van Linthout, Piotr Pruszczyk, Petar Seferović, Andrew J.S. Coats, Marco Metra, Giuseppe Rosano, Stephan Rosenkranz, Carlo G. Tocchetti

Bibliographic record

VenueEuropean Journal of Heart Failure · 2024
Typearticle
Languageen
FieldMedicine
TopicPulmonary Hypertension Research and Treatments
Canadian institutionsSurgical Specialties (Canada)
FundersCilagHORIZON EUROPE Framework ProgrammeNederlandse Federatie van Universitair Medische CentraServierNovo Nordisk FondenGenesis PharmaNovo NordiskNederlandse Organisatie voor Wetenschappelijk OnderzoekZonMwEuropean Society of CardiologyKoninklijke Nederlandse Akademie van WetenschappenDeutsche ForschungsgemeinschaftEuropean CommissionMinisterstvo Zdravotnictví Ceské RepublikySanofiAbiomedCareDxBritish Heart FoundationAmicus TherapeuticsCytokineticsEli Lilly and CompanyU.S. Department of DefenseDeutsches Zentrum für Herz-KreislaufforschungNational Institutes of HealthRegeneron PharmaceuticalsNational Heart, Lung, and Blood InstituteAcceleronUnited Therapeutics CorporationBristol-Myers SquibbAstraZenecaVifor PharmaMinistero della SalutePfizerAmerican Heart Association
KeywordsMedicineHeart failurePulmonary hypertensionClinical endpointClinical trialClinical PracticeCardiologyHypertension treatmentIntensive care medicineInternal medicineBlood pressurePhysical therapy

Abstract

fetched live from OpenAlex

Pulmonary hypertension (PH) associated with left heart failure (LHF) (PH-LHF) is one of the most common causes of PH. It directly contributes to symptoms and reduced functional capacity and negatively affects right heart function, ultimately leading to a poor prognosis. There are no specific treatments for PH-LHF, despite the high number of drugs tested so far. This scientific document addresses the main knowledge gaps in PH-LHF with emphasis on pathophysiology and clinical trials. Key identified issues include better understanding of the role of pulmonary venous versus arteriolar remodelling, multidimensional phenotyping to recognize patient subgroups positioned to respond to different therapies, and conduct of rigorous pre-clinical studies combining small and large animal models. Advancements in these areas are expected to better inform the design of clinical trials and extend treatment options beyond those effective in pulmonary arterial hypertension. Enrichment strategies, endpoint assessments, and thorough haemodynamic studies, both at rest and during exercise, are proposed to play primary roles to optimize early-stage development of candidate therapies for PH-LHF.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.008
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.018
Threshold uncertainty score0.062

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0090.008
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.002
Bibliometrics0.0020.001
Science and technology studies0.0010.002
Scholarly communication0.0050.006
Open science0.0010.003
Research integrity0.0050.008
Insufficient payload (model declined to judge)0.0180.007

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.240
Teacher spread0.221 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations22
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Journal of Heart FailureSame topicPulmonary Hypertension Research and TreatmentsFrench-language works237,207